Why Wall Street Is Worried About Pfizer Despite Its COVID Vaccine Success

·4 min read
Why Wall Street Is Worried About Pfizer Despite Its COVID Vaccine Success

Pfizer (NYSE: PFE) just knocked it out of the park with its first-quarter results. You might think that Wall Street would have been enthusiastic about such a strong quarterly update. Pfizer's shares barely moved after the Q1 results were announced.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting